In today’s world, sustainable practices and environmental consciousness are crucial for the long-term well-being of our planet. Farmson Pharmaceuticals, a leading manufacturer of Active Pharmaceutical Ingredient (API) Paracetamol, recognizes the importance of sustainable operations and has implemented a range of practices to minimize resource consumption, protect the environment, and reduce carbon footprints. In this blog, we will explore Farmson Pharmaceuticals’ approach to sustainable API Paracetamol production and their conscious efforts towards environmental preservation.

Self-Sustenance and Reduced Resource Consumption:

Farmson Pharmaceuticals has achieved self-sustenance by implementing backward integration for their key raw material, Para Amino Phenol (PAP). This strategic decision has eliminated dependencies on Chinese suppliers, reducing resource consumption and ensuring a more reliable supply chain. By locally sourcing PAP, Farmson Pharmaceuticals minimizes transportation-related carbon emissions and contributes to the reduction of their ecological footprint.

Solvent-Free Manufacturing of Paracetamol:

Conscious efforts towards protecting the environment are evident in Farmson Pharmaceuticals’ manufacturing process. They have eliminated the use of solvents in the production of Paracetamol, reducing the emission of volatile organic compounds (VOCs). This solvent-free approach not only ensures a safer working environment for employees but also minimizes the release of harmful chemicals into the atmosphere.

Hydrogenation Technology for Key Starting Material:

Farmson Pharmaceuticals employs hydrogenation technology for the manufacturing of key starting materials. This approach not only ensures the production of high-quality API Paracetamol but also contributes to a more environmentally friendly process. Hydrogenation technology offers several benefits, including reduced energy consumption, improved process efficiency, and a minimized environmental impact compared to traditional manufacturing methods.

Harnessing Alternate Energy Resources:

Farmson Pharmaceuticals is committed to reducing its reliance on conventional energy sources and embracing renewable alternatives. The company has installed solar panels, generating approximately 11% of their total contract demand from clean solar energy. By utilizing solar power, Farmson Pharmaceuticals reduces greenhouse gas emissions and decreases their overall carbon footprint.

Cogeneration and Energy Conservation:

To further enhance their sustainability efforts, Farmson Pharmaceuticals has implemented cogeneration practices. By utilizing back pressure steam turbine power generation, the company generates around 25% of their total contract demand in-house. This approach maximizes energy efficiency and reduces dependence on external energy sources, resulting in both cost savings and a reduced environmental impact.

Green Technology Initiatives:

Farmson Pharmaceuticals has taken proactive steps to address water management and conservation. They have installed a Multiple Effective Evaporator (MEE) plant, which efficiently processes the total effluent, salvaging water resources and minimizing water wastage. This technology ensures that the water used in the production process is conserved and reused, reducing the strain on freshwater sources.

Curbing Carbon Footprints through Glacial Acetic Acid:

Farmson Pharmaceuticals has installed a Glacial Acetic Acid plant, a significant step towards curbing carbon footprints. By concentrating the dilute acetic acid to 99.5% and selling Glacial Acetic Acid, the transportation quantity has been reduced by 218,000 liters per day. This initiative significantly reduces transportation-related emissions and contributes to a more sustainable supply chain.

Farmson Pharmaceuticals demonstrates a commendable commitment to sustainable practices in API Paracetamol production. From backward integration and solvent-free manufacturing to the use of hydrogenation technology and harnessing alternate energy resources, Farmson Pharmaceuticals is leading the way in eco-friendly operations. Through their green technology initiatives and carbon footprint reduction efforts, they are setting an example for the pharmaceutical industry, showcasing how sustainable practices can be integrated into manufacturing processes to protect the environment and contribute to a better future,